Shelter Pharma Limited Achieves A+ Rating in FSSAI Third-Party Food Safety Audit

1 min read     Updated on 18 Mar 2026, 11:52 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Shelter Pharma Limited's manufacturing facility has achieved an A+ rating in a third-party food safety audit conducted under FSSAI regulatory framework. The facility scored 81/86 (94%) in the comprehensive evaluation, demonstrating strong compliance with food safety standards and regulatory requirements. This achievement reflects the company's commitment to maintaining high-quality manufacturing standards and robust safety protocols.

powered bylight_fuzz_icon
35360532

*this image is generated using AI for illustrative purposes only.

Shelter Pharma Limited has successfully completed a third-party food safety audit under the Food Safety and Standards Authority of India (FSSAI) regulatory framework, achieving exceptional results that underscore the company's commitment to quality and safety standards.

Audit Results and Performance

The manufacturing facility of Shelter Pharma Limited underwent a comprehensive evaluation by an FSSAI-recognized third-party auditing agency. The audit was designed to assess compliance with applicable food safety standards and regulatory requirements across the company's operations.

Parameter: Details
Audit Score: 81/86 (94%)
Rating Achieved: A+
Regulatory Authority: Food Safety and Standards Authority of India
Auditing Agency: FSSAI recognized Third Party Auditing Agency
Facility Audited: Manufacturing Facility of Shelter Pharma Limited

Compliance and Quality Standards

The audit results demonstrate Shelter Pharma's strong adherence to prescribed food safety management systems and operational standards. The A+ rating reflects the facility's comprehensive compliance with FSSAI requirements and indicates the company's robust quality control measures.

The evaluation covered various aspects of food safety protocols, including:

  • Manufacturing processes and procedures
  • Quality control systems
  • Regulatory compliance frameworks
  • Operational safety standards

Regulatory Disclosure

Shelter Pharma Limited made this disclosure pursuant to Regulation 30 read with Schedule III – Part A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company informed the Bombay Stock Exchange Limited about the audit completion and results on March 18, 2026.

The successful audit outcome reinforces Shelter Pharma's dedication to maintaining high standards of quality and food safety in its products, positioning the company favorably within the regulatory compliance landscape.

Historical Stock Returns for Shelter Pharma

1 Day5 Days1 Month6 Months1 Year5 Years
-1.44%-0.68%-19.15%-34.04%-18.70%-30.05%

How might this A+ FSSAI rating impact Shelter Pharma's ability to secure new distribution partnerships or expand into international markets?

Will this exceptional audit score enable Shelter Pharma to command premium pricing for its products compared to competitors with lower safety ratings?

What potential regulatory advantages could this A+ rating provide if FSSAI introduces stricter compliance requirements for pharmaceutical manufacturers?

Shelter Pharma Appoints Financial Mindss as Investor Relations and Public Relations Agency

1 min read     Updated on 13 Mar 2026, 11:34 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Shelter Pharma Limited has appointed Financial Mindss (Jai Bharti Capital Advisory Private Limited) as its Investor Relations and Public Relations agency under SEBI Listing Regulations. The appointment, announced on March 13, 2026, aims to strengthen investor communication, stakeholder engagement, media relations, and public relations strategy. Managing Director Mustaqim Nisarahmed Sabugar formally communicated this development to BSE Limited under Script Code 543963.

powered bylight_fuzz_icon
34927462

*this image is generated using AI for illustrative purposes only.

Shelter Pharma Limited has appointed Financial Mindss as its Investor Relations and Public Relations agency, marking a strategic move to enhance its communication and stakeholder engagement capabilities. The appointment was formally communicated to BSE Limited on March 13, 2026, in compliance with regulatory requirements.

Appointment Details

The company has engaged Financial Mindss, operating under the corporate name Jai Bharti Capital Advisory Private Limited, to serve as its dedicated IR and PR agency. The appointment was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Parameter: Details
Agency Name: Financial Mindss
Corporate Entity: Jai Bharti Capital Advisory Private Limited
CIN: U66190MH2024PTC433999
Appointment Date: March 13, 2026
Regulatory Framework: SEBI Listing Regulations 2015

Service Scope and Objectives

Financial Mindss will provide comprehensive Investor and Public Relations Advisory Services to Shelter Pharma Limited. The agency's mandate encompasses several key areas designed to strengthen the company's external communication framework.

The services will focus on:

  • Strengthening investor communication framework
  • Enhanced stakeholder engagement initiatives
  • Comprehensive media relations management
  • Development of overall public relations strategy

Regulatory Compliance

The appointment notification was submitted to BSE Limited under Script Code 543963, ensuring full compliance with listing obligations. Managing Director Mustaqim Nisarahmed Sabugar signed the formal communication, which was digitally authenticated and submitted from the company's Ahmedabad office.

This strategic appointment reflects Shelter Pharma's commitment to maintaining transparent and effective communication channels with its investors and stakeholders while ensuring adherence to regulatory disclosure requirements.

Historical Stock Returns for Shelter Pharma

1 Day5 Days1 Month6 Months1 Year5 Years
-1.44%-0.68%-19.15%-34.04%-18.70%-30.05%

More News on Shelter Pharma

1 Year Returns:-18.70%